subject area of

• A Bright Future for Evolutionary Methods in Drug Design  Academic Article
• A renaissance of neural networks in drug discovery  Academic Article
• Anticipating the anti‐ageing pill  Academic Article
• Artificial Neural Network (ANN) Based Modelling for D1 Like and D2 Like Dopamine Receptor Affinity and Selectivity  Academic Article
• Barminomycin, a Model for the Development of New Anthracyclines  Academic Article
• BioPPSy: An Open-Source Platform for QSAR/QSPR Analysis  Academic Article
• Bioinformatics in protein kinases regulatory network and drug discovery  Academic Article
• Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies  Academic Article
• Changing the scope of preventative and therapeutic approaches in atherothrombosis  Academic Article
• Development of anti-cancer drugs.  Academic Article
• Discovery of Inhibitors of Lupin Diadenosine 5′,5′′′-P1,P4-Tetraphosphate Hydrolase by Virtual Screening  Academic Article
• Discovery of [18F]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: A Melanoma Positron Emission Tomography Imaging Radiotracer with High Tumor to Body Contrast Ratio and Rapid Renal Clearance  Academic Article
• Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL  Academic Article
• Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target  Academic Article
• Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples  Academic Article
• Epitope Discovery and Their Use in Peptide Based Vaccines  Academic Article
• Fragment-based development of a benzofuran hit as a new class of Escherichia coli DsbA inhibitors  Academic Article
• Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment  Academic Article
• Implementation of proteomic biomarkers: making it work  Academic Article
• Manipulating Eryptosis of Human Red Blood Cells: a Novel Antimalarial Strategy?  Academic Article
• Mitoxantrone, More than Just Another Topoisomerase II Poison  Academic Article
• Modelling and enhanced molecular dynamics to steer structure-based drug discovery  Academic Article
• Novel immunomic technologies for schistosome vaccine development  Academic Article
• Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs  Academic Article
• Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting  Academic Article
• Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V  Academic Article
• Stachyonic Acid: A Dengue Virus Inhibitor from Basilicum polystachyon  Academic Article
• Strategies for the discovery and development of therapies for metastatic breast cancer  Academic Article
• Structure guided design of biotin protein ligase inhibitors for antibiotic discovery  Academic Article
• Synthesis and Preliminary Screening of Novel Tryptamines as 5-HT4 Receptor Ligands  Academic Article
• Targeting bacterial Dsb proteins for the development of anti-virulence agents  Academic Article
• The Bcl-2 family: structures, interactions and targets for drug discovery  Academic Article
• The Eighth Annual Ion Channel Retreat, Vancouver, Canada, June 28–30, 2010  Conference Paper
• The Use of Tripeptides for Lead Discovery of 5-HT4 Receptor Ligands  Academic Article
• Transition State Mimetics of the Plasmodium Export Element Are Potent Inhibitors of Plasmepsin V from P-falciparum and P-vivax  Academic Article
• Unexpected link between an antibiotic, pannexin channels and apoptosis  Academic Article
• miRNA therapeutics: A new class of drugs with potential therapeutic applications in the heart  Academic Article
• ‘Click’ assembly of glycoclusters and discovery of a trehalose analogue that retards Aβ40 aggregation and inhibits Aβ40-induced neurotoxicity  Academic Article